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The inappropriate retention of neutrophils at inflammatory sites is a major driver of the
excessive tissue damage characteristic of respiratory inflammatory diseases including
COPD, ARDS, and cystic fibrosis. The molecular programmes which orchestrate
neutrophil recruitment to inflammatory sites through chemotactic guidance have been
well-studied. However, how neutrophil sensitivity to these cues is modulated during
inflammation resolution is not understood. The identification of neutrophil reverse
migration as a mechanism of inflammation resolution and the ability to modulate this
therapeutically has identified a new target to treat inflammatory disease. Here we
investigate the role of the CXCL12/CXCR4 signaling axis in modulating neutrophil
retention at inflammatory sites.We used an in vivo tissue injury model to study neutrophilic
inflammation using transgenic zebrafish larvae. Expression of cxcl12a and cxcr4b during
the tissue damage response was assessed using in situ hybridization and analysis of
RNA sequencing data. CRISPR/Cas9 was used to knockdown cxcl12a and cxcr4b in
zebrafish larvae. The CXCR4 antagonist AMD3100 was used to block the Cxcl12/Cxcr4
signaling axis pharmacologically. We identified that cxcr4b and cxcl12a are expressed at
the wound site in zebrafish larvae during the inflammatory response. Following tail-fin
transection, removal of neutrophils from inflammatory sites is significantly increased
in cxcr4b and cxcl12a CRISPR knockdown larvae. Pharmacological inhibition of the
Cxcl12/Cxcr4 signaling axis accelerated resolution of the neutrophil component of
inflammation, an effect caused by an increase in neutrophil reverse migration. The
findings of this study suggest that CXCR4/CXCL12 signaling may play an important role
in neutrophil retention at inflammatory sites, identifying a potential new target for the
therapeutic removal of neutrophils from the lung in chronic inflammatory disease.
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INTRODUCTION
The inappropriate retention of activated innate
inflammatory cells at inflammatory sites is major driver of
chronic inflammatory diseases including asthma, COPD and
rheumatoid arthritis (1). Neutrophils are one of the first
cell types recruited to sites of inflammation, where they are
potent anti-microbial effectors through the phagocytosis of
foreign material, generation of reactive oxygen species and
the production of extracellular traps (2–4). These non-specific
anti-microbial mechanisms promote a tissue microenvironment
which is unfavorable to pathogens, but at the expense of host
tissue integrity (5). Neutrophil removal from inflammatory
sites is therefore tightly regulated to minimize collateral tissue
damage, thereby preventing chronic inflammatory disease (6).
Despite the global burden of chronic inflammatory diseases,
there are currently no effective therapies to treat the neutrophilic
component of these conditions, highlighting a need to identify
novel drug targets to promote the successful resolution
of inflammation.
It has been known for 30 years that neutrophils undergo
apoptosis followed by efferocytosis by macrophages, and this
is the best characterized mechanism by which neutrophils are
removed from inflammatory sites (7, 8). Although methods to
both accelerate and delay apoptosis have been identified (9–
13), none of these are yet in clinical use for inflammatory
disease. More recently, reverse migration has been identified
as a mechanism by which neutrophils redistribute into the
tissue or vasculature surrounding the inflammatory site, an
anti-inflammatory mechanism which is thought to disperse
the inflammatory burden (10, 11, 14, 15). Reverse neutrophil
migration has been visualized in vivo using transparent zebrafish
larvae (10, 16–18), as well as in mice (14) and human
neutrophils (19). In vitro studies using microfluidics devices
identified that over 90% of human neutrophils can reverse
their directionality away from a chemoattractant over distances
of 1,000µm (20). The mechanisms governing this newer
phenomenon are not fully understood, though it is clear
that the capacity of neutrophils to cause host tissue damage
is increased when either apoptosis or reverse migration are
impaired, resulting in the inappropriate retention of neutrophils
at the inflammatory site (21). Understanding neutrophil
reverse migration represents novel therapeutic avenues to treat
neutrophil mediated chronic inflammation.
During inflammation, neutrophils respond to complex
guidance cues provided in part by chemokine gradients which
promote the directed migration of neutrophils from the
circulation and into inflamed tissues (22). More recently, a
role for chemokine signaling in modulating neutrophil reverse
migration has been identified (15, 18), making chemokine
receptors an attractive target for investigation. Computational
modeling and in vivo studies of reverse migration have shown
that this process likely occurs as a result of the stochastic
redistribution of neutrophils following their desensitization to
local chemotactic gradients over time (11, 16, 18). In zebrafish,
neutrophil reverse migration can be delayed by stabilizing
HIF1α which promotes neutrophil retention at inflammatory
sites (10), suggesting that downstream HIF signaling targets
retain neutrophils at inflammatory sites. Work by our group
and others has shown that this retention of neutrophils at
inflammatory sites is both mechanistically important (10, 21),
and can be manipulated therapeutically (11, 13, 18), yet the
molecular mechanisms remain to be elucidated.
CXCR4 is a G protein coupled receptor expressed by many
leukocytes, which exerts its biological functions by signaling
through its major ligand CXCL12 (formerly known as stromal
derived factor 1). CXCL12/CXCR4 signaling is a key retention
signal for neutrophil release into the blood circulation from
hematopoietic tissues, the crucial role of which is highlighted
in patients with warts, hypogammaglobulinaemia, infection, and
myelokathesis (WHIM) syndrome. Gain of function WHIM
mutations result in increased CXCR4 signaling, the consequence
of which is severe neutropenia with increased neutrophil
retention in the bone marrow (23).
There is growing evidence to support a role for
CXCL12/CXCR4 in neutrophil retention in the context
of inflammatory disease. Tissue infiltrated neutrophils
from patients with chronic inflammatory lung diseases and
rheumatoid arthritis have increased CXCR4 surface expression
(24). Neutrophil surface expression of CXCR4 is increased after
extravasation into injured lungs in mice (25) and in human
tissue samples, where pulmonary CXCL12 expression increases
during acute lung injury (26). Additionally, the inhibition of
CXCL12 using blocking antibodies prevented the accumulation
of neutrophils in the lung during the late stages of LPS induced
lung injury (25). Based on this evidence we hypothesized that
CXCL12/CXCR4 functions as a retention signal in the context of
tissue damage, functioning to maintain active neutrophils at the
inflammatory site.
Here we present a new role for the CXCL12/CXCR4 signaling
axis in the retention of neutrophils at inflammatory sites
and demonstrate a role for neutrophil retention signaling in
modulating inflammation resolution in zebrafish larvae. Using
both pharmacological and genetic approaches to manipulate
the CXCL12/CXCR4 signaling axis, we demonstrate that
interruption of CXCR4 signaling increases neutrophil reverse
migration. We have identified a druggable signaling axis which
could be a therapeutic target to remove excessively retained
neutrophils at inflammatory sites during disease.
MATERIALS AND METHODS
Zebrafish Husbandry and Ethics
To study neutrophils during inflammation
TgBAC(mpx:EGFP)i114 (known as mpx:GFP) (27) zebrafish
larvae were in-crossed. To study gene expression by whole
mount in situ hybridization, wildtype pigment-less nacre
(28) larvae were in-crossed. For reverse migration assays,
Tg(mpx:GAL4.vp16)sh267;Tg(UAS:Kaede)i222 (known as
mpx:kaede) were in-crossed.
All zebrafish were raised in the Bateson Centre at the
University of Sheffield in UK Home Office approved aquaria
and maintained following standard protocols (29). Tanks were
maintained at 28◦Cwith a continuous re-circulating water supply
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and a daily light/dark cycle of 14/10 h. All procedures were
performed on embryos <5.2 dpf which were therefore outside of
the Animals (Scientific Procedures) Act, to standards set by the
UK Home Office.
Neutrophil Specific Expression of
Zebrafish Genes
Gene expression was assessed using an RNA sequencing database
from FACS sorted GFP positive cells from 5 dpf zebrafish and
FPKM values for genes of interest were extracted (30) (data
deposited on GEO under accession number GSE78954). For
single cell analysis, gene expression values were extracted from
the BASiCz (Blood atlas of single cells in zebrafish) cloud
repository (31). Cells of the neutrophil lineage were analyzed for
expression of cxcr4a, cxcr4b, cxcl12a, and cxcl12b.
WISH Probe Synthesis
The WISH antisense RNA probe for cxcl12a was synthesized
from linearised plasmid DNA obtained from a plasmid vector
containing the zebrafish cxcl12a coding sequence. Following
transformation and DNA purification, the plasmid was linearised
by restriction digest using EcoR1 [New England Biolabs (NEB),
Herts, UK]. The RNA probe was transcribed from linearised
DNA using an SP6 RNA digoxigen labeling kit (Roche). One
µg of linearised DNA was incubated in a final volume of 20 µl
containing transcription reagents and transcription reaction was
performed according to standard protocols (Roche).
Whole Mount in situ Hybridization
Nacre larvae were anesthetized in tricaine following tail fin
transection at time points indicated in the figure legends
alongside uninjured, age-matched controls. No more than 20
larvae were transferred to 1ml Eppendorf tubes and excess
liquid was removed without damaging larvae. One ml of
paraformaldehyde (PFA) at 4◦C was added to Eppendorf tubes
for the fixation step, and left overnight at 4◦C. Larvae were
washed and transferred into 100%methanol and stored at−20◦C
for at least 24 h prior to use. WISH was performed using
standard protocols (32) using an antisense DIG labeled probe for
zebrafish cxcl12a.
CRISPR/Cas9 Reagents
Synthetic SygRNA R© consisting of crRNA and tracrRNA
(Merck) in combination with Cas9 nuclease protein (Merck)
was used for gene editing. Transactivating RNAs (tracrRNA)
and gene specific CRISPR RNAs (crRNA) were resuspended
to a concentration of 20µM in nuclease free water containing
10mM Tris-HCl pH8. SygRNA R© complexes were assembled
on ice immediately before injection using a 1:1:1 ratio of
crRNA:tracrRNA:Cas9 protein. Gene-specific crRNAs to
target cxcr4b and cxcl12a were designed using the online tool
CHOPCHOP (http://chopchop.cbu.uib.no/). We used the
following crRNA sequences, where the PAM site is indicated
in brackets: cxcr4b: CAGCTCTGACTCCGGTTCTG(GGG)
cxcl12a: CTCTACCAGGCTGATGGGCT(TGG).
Microinjection of SygRNA® Into Embryos
A 1 nl drop of SygRNA R©:Cas9 protein complex was injected
into mpx:GFP embryos at the one-cell stage. Embryos were
collected at the one cell stage and injected using non-filament
glass capillary needles [Kwik-FilTM Borosilicate Glass Capillaries,
World Precision Instruments (WPI), Herts, UK]. RNA was
prepared in sterile Eppendorf tubes. A graticule was used to
measure 0.5 nl droplet sizes to allow for consistency of injections.
Injections were performed under a dissecting microscope
attached to a microinjection rig (WPI) and a final volume of 1
nl was injected.
Genotyping of Crispant Larvae
To determine the efficiency of CRISPR/Cas9 to induce site-
specific mutations in injected larvae, we used restriction digest
assays (Supplemental Figure 2). CRISPR guides were designed
to target sequences containing restriction digest sites, such that
when indels were introduced by DNA repair, the restriction
site is disrupted. Genomic DNA was extracted from individual
larvae at 2 dpf. Larvae were placed individually in 0.2ml PCR
tubes in 90 µl 50mM NaOH and boiled at 95◦ for 20min.
Ten µl Tris-HCl pH 8 was added as a reaction buffer and
mixed thoroughly. RT-PCR using Firepol R© (Solis BioDyne)
was used to amplify a 235 bp region (for cxcr4b) and a 259
bp region (for cxcl12a) around the PAM site. Gene specific
primers were designed using the Primer 3 web tool (http://
primer3.ut.ee/). Primer sequences were as follows: cxcrb4_fw
TCCCGTATACTGTAGGGAGGA cxcr4b_rev TTTTTGCATTT
TGTTTTCTTG cxcl12a_fw TTCTCTGTGGGACTGTGTTGAC
cxcl12a_rev TTCGAAAATTTGACCCAAAAGT. Restriction
enzyme digests were then performed using bsII at 55◦ for 2 h
(for cxcr4b) and bstXi (New England Biolabs) at 37◦ for 2 h (for
cxcl12a). Products were run using gel electrophoresis on a 2% gel
(Supplemental Figure 2).
Inflammation Assays in Crispant Larvae
To induce an inflammatory response, chorions of zebrafish larvae
at 2 dpf were removed using sterile laboratory tweezers and larvae
were anesthetized in Tricaine (0.168 mg/ml; Sigma-Aldrich) in
E3 media and visualized under a dissecting microscope. Tail-
fins were transected consistently using a scalpel blade (5mm
depth, WPI) by slicing immediately posterior to the circulatory
loop, ensuring the circulatory loop remained intact as previously
described (27). Larvae weremaintained at 28◦C in fresh E3media
in a 24 well plate. Neutrophils at the wound site were counted
at timepoints indicated in figure legends using a fluorescence
stereo microscope.
Compound Treatment of Larvae for
Inflammation Resolution Assays
To study the resolution of inflammation, neutrophils were
counted at the wound site at intervals during the resolution phase
from 8 to 24 h post injury in 2 dpf mpx:GFP larvae, as indicated
in figure legends. Larvae were dechorionated and anesthetized
prior to injury by tail-fin transection and left to recover at 28◦C in
fresh E3 media in petri dishes (60 larvae per plate). Larvae were
screened for good neutrophil recruitment (around 20 neutrophils
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at the wound site) at 3.5 hpi. AMD3100 (Sigma-aldrich) was
administered to larvae at 4 hpi through injection into the duct of
Cuvier at a final concentration of 20µM. AMD3100 was always
tested alongside the appropriate vehicle control. Neutrophils at
the wound site were counted at 6 hpi at the peak of recruitment,
and at 8 hpi for inflammation resolution using a fluorescence
stereo microscope (Leica).
Percentage Resolution Calculations
To determine resolution of the neutrophil component of
inflammation, experiments were performed with larvae
maintained separately in a 96 well plate to follow individual
larvae over time. Percentage reduction in neutrophil counts
at the wound was calculated as [(Neutrophil counts at peak
recruitment – neutrophil counts at 8hpi)/neutrophil counts at
peak recruitment]∗100.
Whole Body Neutrophil Counts
Whole body neutrophil counts were measured in mpx:GFP
larvae at time points indicated in figure legends. Larvae were
mounted in 1% agarose with tricaine and a single slice image
was taken using a 4x NA objective lens on an Eclipse TE2000U
inverted compound fluorescence microscope (Nikon UK Ltd.,
Kingston upon Thames, UK). A GFP-filter was used at excitation
of 488 nm. Two images were taken per larvae, one of the head
region and one of the tail region. Neutrophils were counted
manually from both images and combined to give a whole body
neutrophil count.
Reverse Migration Assay
Reverse migration assays were performed using larvae expressing
the photoconvertible protein kaede under the neutrophil specific
mpx promoter: TgBAC(mpx:GAL4-VP16); Tg(UAS:Kaede)i222.
At 3 dpf larvae were anesthetized and injured by tail-fin
transection and left to recover at 28◦C. Larvae were screened
for good neutrophil recruitment at 4 hpi. AMD3100 was
administered by incubation in low melting point agarose
containing tricaine at 5 hpi in 3 dpf larvae. Photoconverstion
of kaede labeled neutrophils at the wound site was performed
using an UltraVIEWPhotoKinesisTM device (Perkin Elmer
and Analytical Sciences) on an UltraVIEWVoX spinning
disc confocal laser imaging system (Perkin Elmer). The
photokinesis device was calibrated using a coverslip covered
in photobleachable substrate (Stabilo BossTM, Berks UK).
Photoconverstion was perfomed using a 405 nm laser at 40%
using 120 cycles, 250 pk cyles and 100ms as previously published
(10). Following calibration, a region of interest was drawn
at the wound site between the edge of the circulatory loop
and encapsulating the entirety of the wound edge. Successful
photoconversion was detected through loss of emission detected
following excitation at 488 nm, and gain of emission following
561 nm excitation. Larvae were then transferred to an Eclipse
TE2000-U inverted compound fluorescence microscope with
10x NA objective lense to acquire images using an andor zyla
5 camera (Nikon). Time lapse imaging of neutrophil reverse
migration was performed for 5 h using 2.5min intervals using
GFP and mCherry filters with 488 and 561 nm excitation,
respectively. For quantification of reverse migration, NIS
elements software was used to compress z-slices into maximum
intensity projections. A region of interest was drawn around
the region away from the wound site. For quantification of
neutrophils moving away from the wound site, a binary threshold
was applied to images to detect mCherry neutrophils from
background noise and NIS elements software calculated the
number of objects detected in the ROI at each time point,
providing a read out of reverse migration.
RESULTS
cxcr4b and cxcl12a Are Expressed
Following Tissue Damage in Zebrafish
Zebrafish have two paralogues for CXCR4 and CXCL12,
following a genome duplication event in teleost evolution.
The expression of cxcr4a and cxcr4b is mutually exclusive in
most cell lineages, indicating partitioned ancestral functions in
different tissues (33). In zebrafish larvae Cxcl12a is produced
in regions of neutrophil development alongside expression in
the head, pronephric duct and CHT of zebrafish larvae at 2dpf
(34), as well as in the regenerating fins of adult zebrafish (35,
36). To determine the gene expression of Cxcr4 and Cxcl12
during the cellular response to tissue damage in zebrafish
larvae, we first investigated neutrophil expression of cxcr4
and cxcl12. We studied published datasets combining RNA
sequencing of mpx:GFP positive zebrafish larval neutrophils
and single-cell RNA sequencing data from adult zebrafish blood
lineages (30, 31). In adult zebrafish neutrophils, cxcr4b is highly
expressed by the neutrophil lineage whilst cxcr4a is undetectable
(Figures 1A,B). Cxcl12a is expressed by a small population
of adult zebrafish neutrophils, albeit far fewer than cxcr4b,
whilst cxcl12b is expressed by very few cells (Figures 1C,D).
We analyzed larval stage neutrophil RNA sequencing data (30),
and found that fragments per kilobase million (fpkm) values
for cxcr4b were over 100-fold higher than the fpkm values for
cxcr4a (Figure 1E), confirming that cxcr4b is the predominantly
expressed isoform in larval zebrafish neutrophils. Furthermore,
we confirmed that expression of cxcl12a and cxcl12b was low in
larval neutrophils (Figure 1F).
Zebrafish Cxcr4b is activated by the chemokine Cxcl12a
(37), we therefore investigated the expression of cxcl12a
during the inflammatory response in 3dpf larvae. To induce
an inflammatory response we used our well-characterized
tail-fin injury model of spontaneously-resolving neutrophilic
inflammation (27), where neutrophil recruitment is observed
between 0 and 6 h post injury (hpi) and resolution of the
neutrophilic component of inflammation occurs between 6 and
24 hpi. Whole mount in situ hybridization was used to detect
cxcl12a mRNA at the wound site in 3 dpf larvae following
tail fin transection. Cxcl12a mRNA expression was detected in
injured larvae as early as 6 hpi during the recruitment phase
(Figure 1G). Interestingly, cxcl12a mRNA expression continued
to increase throughout the resolution phase up to 24 hpi
(Figure 1G) in keeping with other reports of cxcl12 expression
following fin injury. These findings show the expression of cxcr4b
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FIGURE 1 | cxcr4b and cxcl12a are expressed following tissue damage in zebrafish. (A–D) Single-cell gene expression profiles for cxcr4 and cxcl12 in the zebrafish
blood lineage. Single cell gene expression values extracted from the Sanger BASiCz zebrafish blood atlas. Circles represent individual cells color coded where red is
high expression and yellow is no expression. Neutrophil lineage (mpx:GFP positive) is highlighted by black dashed box and expanded in (i–iv). (E,F) RNA sequencing
of FACS sorted GFP positive cells from TgBAC(mpx:GFP)i114 zebrafish larvae at 5 days post fertilization. FPKM values illustrate neutrophil expression of (E) cxcr4a
and cxcr4b and (F) cxcl12a and cxcl12b. (G) Whole mount in situ hybridization using an antisense DIG labeled RNA probe for cxcl12a mRNA. Wildtype nacre
zebrafish larvae were injured and fixed in PFA at 6, 12, and 24 h post injury, along with uninjured age-matched control larvae. Left and middle panels show whole
zebrafish larvae at timepoints indicated, right panel shows tail fins of a representative experiment. Quantification shows number of larvae which look like representative
image from 2 independent experiments.
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by neutrophils and cxcl12a at the tissue injury site during the
inflammatory response in zebrafish.
Genetic Manipulation of the
CXCL12/CXCR4 Signaling Axis
Accelerates Inflammation Resolution
After determining that cxcl12a was expressed at the wound site
in injured larvae, we next investigated neutrophil responses to
tissue injury in the absence of the CXCL12/CXCR4 signaling
axis. We hypothesized that if CXCL12/CXCR4 signaling
was a neutrophil retention signal, inhibition of this pathway
would accelerate neutrophil removal from the tissue injury
site. We used CRISPR/Cas9 to study the role of Cxcl12a and
Cxcr4b in neutrophilic inflammation resolution using the
TgBAC(mpx:GFP)i114 transgenic reporter line (27). A crRNA
targeting the pigment gene tyrosinase (tyr) (38) was used
for control injections and to allow for visual identification of
successful knockdown. Knockdown of tyr produces an albino
phenotype in zebrafish larvae (Supplemental Figures 1A,B)
without affecting neutrophil development or the neutrophilic
inflammatory response (Supplemental Figures 1C,D). We
generated cxcr4b or cxcl12a “crispants” (newly generated “F0”
CRISPR/Cas9-mediated mutants) and transected tail-fins at 2
dpf, counting neutrophils at the wound site at 4, 8, and 24 hpi
(Figures 2A,B). Neutrophil counts in cxcr4b crispants were
significantly increased at the wound site during the neutrophil
recruitment phase (4 hpi), consistent with enhanced release
of cxcr4b mutant neutrophils from their site of production
(39) (Figure 2B). Cxcl12a crispants showed no difference in
neutrophil recruitment (Figure 2B). No significant difference
in neutrophil numbers at the wound site was detected between
groups at 8 and 24 hpi (Figure 2B). We assessed the difference
in neutrophil counts at the wound site between 4 and 8 hpi
in each group. No significant difference in neutrophil number
at the wound site was detected in control larvae, whilst both
cxcr4b and cxcl12a crispants exhibited a significant decrease
in neutrophil number (Figure 2C), suggesting neutrophil
removal from the wound site in increased compared to control.
To control for the increase in early neutrophil recruitment
measured in Cxcr4b crispants, we calculated percentage
reduction in neutrophil counts at the wound in individual larvae
between 4 and 8 hpi. Both Cxcr4b and Cxcl12a crispants had
significantly higher percentage reduction in wound neutrophils
compared to control larvae (Figure 2D). Whole body neutrophil
numbers were not affected in cxcr4b crispants, but were
significantly reduced in cxcl12a crispants (Figure 2E). These
data demonstrate that loss of Cxcl12/Cxcr4 signaling accelerates
resolution of the neutrophilic component of inflammation
in zebrafish larvae, suggesting that the CXCL12/CXCR4
signaling axis is required for neutrophil retention at
inflammatory sites.
Pharmacological Inhibition of CXCR4
Accelerates Inflammation Resolution
Genetic knockdown of CXCR4 signaling causes neutrophil
release from the caudal haematopoietic tissue (CHT),
enhancing neutrophil recruitment, confounding assessment
of inflammation resolution. To circumvent this, we
used the CXCR4 antagonist AMD3100 to block CXCR4
signaling in a time-sensitive fashion (Figure 3A). At 8 hpi
a significant decrease in neutrophil counts at the wound
site was detected in AMD3100 treated larvae (Figure 3B).
Percentage inflammation resolution was significantly higher
in AMD3100 treated larvae (Figure 3C), whilst whole
body neutrophil counts were not affected by AMD3100
at 24 h post administration (Figure 3D). Together these
data demonstrate that pharmacological inhibition of
CXCR4 in larvae which have mounted a normal response
accelerates resolution of the neutrophilic component of
inflammation, further supporting a role for CXCL12/CXCR4
signaling in neutrophil retention signaling at sites of
tissue damage.
Inhibition of CXCL12/CXCR4 Signaling
Increases Neutrophil Reverse Migration
Two principal mechanisms of inflammation resolution have
been described: neutrophil apoptosis followed by efferocytosis
by macrophages, and reverse migration of neutrophils away
from inflammatory sites. In zebrafish larvae, neutrophil reverse
migration is the predominant mode of inflammation resolution
(10, 11, 40). We have previously proposed that neutrophil
release from inflammatory sites is best explained by the
desensitization of neutrophils to local chemokine gradients
(16). This led us to the specific hypothesis that inhibition of
CXCL12/CXCR4 signaling would accelerate reverse migration
by accelerating neutrophil desensitization to CXCL12 gradients.
To study neutrophil reverse migration, we used a well-described
photoconversion approach to study the reverse migration of
neutrophils from a wound site (10, 11, 13, 17). AMD3100 was
administered to TgBAC(mpx:GAL4-VP16); Tg(UAS:Kaede)i222
(referred to as mpx:kaede) larvae at 5 hpi and neutrophils
at the wound site were photoconverted and tracked during
the resolution phase (Figure 4A). Neutrophil migration away
from the wound site was significantly higher in larvae treated
with AMD3100 (Figure 4B), an effect which was not due to
a difference in the number of photoconverted neutrophils
(Figure 4C). Together these data demonstrate that inhibition of
CXCL12/CXCR4 signaling can increase inflammation resolution
by accelerating neutrophil reverse migration, identifying this
signaling axis as a potential therapeutic target to specifically
remove inflammatory neutrophils without affecting the
normal recruitment of neutrophils to new inflammatory or
infectious lesions.
DISCUSSION
A large body of evidence now exists to suggest a role for
the CXCL12/CXCR4 signaling axis in modulating neutrophil
behavior in chronic inflammatory disease. Aside from generation
of neutrophil retention signals in multiple physiological
settings (41, 42), neutrophils taken from patients with chronic
inflammatory disease have increased CXCR4 expression, and
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FIGURE 2 | Knockdown of cxcr4b using CRISPR/Cas9 accelerates inflammation resolution. (A) Experimental schematic of CRISPR/Cas9 experiments in 2dpf
mpx:GFP larvae. (B–D) CRISPR/Cas9-mediated knockdown of cxcr4b and cxcl12a accelerates inflammation resolution. (B) Time course of neutrophils at the wound
site in control tyr crispant larvae (black line), cxcr4b crispant larvae (blue line), and cxcl12a crispant larvae (pink line) at 4, 8, and 24 hpi. Error bars shown are mean ±
SEM. Groups were analyzed using an ordinary one-way ANOVA and adjusted using Tukey’s multi comparison test. ****p < 0.001 n = 36 from 3 independent
experiments. (C) Neutrophils at the wound site in individual larvae (black dots) at 4 and 8 h post injury in tyr crispant larvae (black), cxcr4b crispant larvae (blue), and
cxcl12a crispant larvae (pink). Groups were analyzed using a paired t-test. ****p < 0.001 n = 36 from 3 independent experiments. (D) Resolution of the neutrophil
component of inflammation was calculated between 4 and 8 hpi. Groups were analyzed using an ordinary one-way ANOVA and adjusted using Tukey’s multi
comparison test. *p < 0.04, **p < 0.004. (E) Whole body neutrophil numbers were measured in mpx:GFP crispant larvae at 2 dpf. n = 30–35 per group from 3
independent experiments. Error bars shown are mean ± SEM. Groups were analyzed using an ordinary one-way ANOVA and adjusted using Tukey’s multi
comparison test, **p < 0.005.
CXCL12 is produced at sites of injury, including the lung
(24, 25). A specific role for the CXCL12/CXCR4 signaling
axis in retaining neutrophils in the CHT has recently been
suggested following the study of neutrophil behavior in
zebrafish Cxcr4b and Cxcl12a mutant larvae (39). Our study
provides evidence that the CXCL12/CXCR4 signaling axis is
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FIGURE 3 | Inhibition of CXCR4 using AMD3100 accelerates inflammation resolution. (A) Experimental schematic of inflammation resolution experiments with
AMD3100 compound treatment. (B) Number of neutrophils at the wound site in injured 2 dpf mpx:GFP larvae treated with AMD3100 or vehicle control at 8 hpi.
Groups were analyzed using an unpaired t-test, ***p < 0.0002, n = 55 larvae from 5 independent experiments. (C) Resolution of the neutrophil component of
inflammation for larvae treated with vehicle control or AMD3100. Groups were analyzed using an unpaired t-test, **p < 0.008 n = 32 larvae from 3 independent
experiments. (D) Whole body neutrophil counts in 3 dpf mpx:GFP larvae 24 h post administration of AMD3100 or vehicle control. Groups were analyzed using an
unpaired t-test, n = 26 larvae from 3 independent experiments.
FIGURE 4 | Inhibition of CXCR4 using AMD3100 accelerates neutrophil reverse migration. (A) Experimental schematic of neutrophil reverse migration assay. Tail fin
transection was performed on 3 dpf mpx:kaede larvae. Larvae were mounted in a 1% agarose solution containing AMD3100 or vehicle control at 5 hpi. Neutrophils at
the wound site were photoconverted at 5 hpi from green to red fluorescence. Time lapse imaging was performed from 7 to 12hpi. (B) The number of neutrophils
which moved away from the wound site into a defined region of interest was quantified from 7 to 12 h post injury in larvae treated with a vehicle control (black) or
AMD3100 (red). Error bars shown are SEM, line of best fit shown is calculated by linear regression. P-value shown is for the difference between the two slopes
p < 0.0001, n = 35 larvae from 6 independent experiments. (C) Number of neutrophils photoconverted between 5 and 6 h post injury in larvae treated with vehicle
control or AMD3100. Data shown are mean ± SEM, groups were analyzed using an unpaired t-test.
important in modulating neutrophil migration away from sites
of inflammation, identifying a potential new therapeutic target
for chronic inflammatory disease.
Computational modeling of reverse migration previously
performed by our group demonstrated that neutrophil
reverse migration is best described as a process of stochastic
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redistribution of neutrophils back into the tissue rather than
their active migration away from the wound site (16). These data
further support our suggestion that neutrophil reverse migration
is initiated following desensitization to chemokine gradients
at the wound site rather their active migration away from
chemorepulsive gradients (fugetaxis). Cellular desensitization to
external gradients is a characteristic feature of signaling through
G protein coupled receptors, many of which are expressed on
the surface of neutrophils (43). A retention signal generated
through chemokine receptor signaling would require expression
of the chemokine within the inflamed tissue and the receptor on
the neutrophil surface. Our analysis of RNA sequencing from
FACS sorted zebrafish larval neutrophils and adult single-cell
RNA sequencing shows that at both larval and adult stages of
development, the predominantly expressed isoform of CXCR4 in
zebrafish neutrophils is cxcr4b, whilst cxcr4a was undetectable.
This is in keeping with RT-PCR performed on FACS sorted larval
zebrafish neutrophils (34). Interestingly, RT-PCR performed on
adult zebrafish whole kidney marrow suggests that both cxcr4b
and cxcr4a are expressed by neutrophils in the adult stage (34).
Our analysis of single-cell RNA sequencing data provides a more
sensitive assay to look at individual neutrophil RNA expression,
therefore it is likely that zebrafish neutrophils do not express
cxcr4a in adulthood. Furthermore, we demonstrate that mRNA
for the major ligand for this receptor, Cxcl12a, is expressed at
the wound site during inflammation. The cxcl12a expression
pattern we observed in uninjured larvae was comparable to that
observed by other groups earlier in zebrafish development at
2dpf (34). Expression of cxcl12a mRNA appeared to increase
at the wound site throughout the time course of inflammation,
in keeping with a significant body of evidence that illustrates
a role for CXCL12 in tissue repair (35, 36, 44). It has been
proposed that Cxcl12a is important in providing directional
guidance cues to regulate endothelial cell migration during
arterial morphogenesis in the regenerating fin (45). Expression
of cxcl12a is detected by WISH in injured adult tail fins from 1
day post amputation and persists during fin regeneration until 5
days post amputation (35).
The role for the CXCL12/CXCR4 signaling axis in zebrafish
developmental processes has been elucidated largely using
genetic studies to knock down the genes encoding the CXCR4
and CXCL12 proteins (37, 46, 47). The high efficiency of
somatic mutation by CRISPR/Cas9 in injected F0 animals
yields up to 99% somatic mutagenesis and biallelic gene
disruption, enabling direct phenotypic analysis without the
requirement for raising stable F2 adults (38, 48, 49). When
using CRISPR/Cas9 to disrupt cxcr4b and cxcl12a, we achieved
genomic disruption by introducing INDELs in >90% injected
F0 larvae (Supplemental Figure 2). In our studies, knockdown
of cxcr4b increased neutrophil recruitment to the wound site in
crispant larvae. C-terminal truncations of Cxcr4b specifically in
neutrophils (such as those found in WHIM syndrome patients)
prevents receptor internalization and increases sensitivity
to Cxcl12a gradients, thus retaining them in the caudal
hematopoietic tissue (CHT) inappropriately (34). Neutrophils
in WHIM zebrafish larvae are unable to respond to wound-
generated gradients effectively, hence neutrophil recruitment to
inflammatory sites is reduced in these larvae (34). Conversely, in
the Cxcr4b odysseus mutant where Cxcr4b signaling is impaired,
the number of neutrophils available to be recruited to tissue
damage is increased (39), thus our findings are in keeping with
the F2 mutant phenotype (39). Neutrophil recruitment toward
Cxcl12a was not increased in our experiments, although this
could be attributed to Cxcl12a larvae displaying significantly
reduced whole body neutrophil counts. Inflammation resolution
was significantly increased in both Cxcr4b and Cxcl12a crispant
larvae, suggesting that genetic manipulation of both genes results
in the same effect in terms of inflammation resolution.
One of the advantages of using the zebrafish as a model to
study inflammation is that chemical compounds can be used
to manipulate signaling pathways, where several compounds
which target neutrophils have been identified using this approach
(9, 11, 12). AMD3100 is a non-peptide bicyclam which is able
to specifically antagonize the CXCR4 receptor at three main
interaction residues located around the main ligand binding
pocket of CXCR4 in transmembrane domains IV, VI and VII.
Binding of AMD3100 competitively inhibits binding of CXCL12
and prevents subsequent downstream signaling (50). AMD3100
has been used to inhibit the CXCL12/CXCR4 signaling axis
in zebrafish larvae, where concentrations ranging from 10 to
30µM have been administered to larvae through incubation
in fish water for up to 24 h (51), a concentration range which
we remained within for our own experiments. Our results
from both genetic and pharmacological manipulation of Cxcr4b
and Cxcl12a demonstrate that inhibition of CXCL12/CXCR4
signaling accelerates inflammation resolution. We propose that
AMD3100 is able to accelerate inflammation and reverse
migration by competitively binding the CXCR4 receptor and
preventing signaling downstream, thus recapitulating what
would happen at a higher concentration of Cxcl12a later in the
inflammatory response. AMD3100 can also act as an allosteric
agonist of CXCR7 (52), which functions as a decoy receptor
for CXCL12, with a role in cell generation of self-gradients
which is crucial for proper migration of primordial germ cells
toward their targets in zebrafish (53). Activation of CXCR7
fails to couple to G-proteins and to induce chemokine receptor
mediated cellular responses, so AMD3100 is unlikely to activate
downstream signaling pathways (54). Cxcr7 may modulate
neutrophil sensitivity to Cxcl12, through its scavenging of the
chemokine which reduces the level of Cxcl12 in the local tissue
environment (55). However, as zebrafish larval neutrophils do
not express this receptor (30) (data not shown), it is unlikely that
scavenging through Cxcr7 is involved.
Reverse migration is impaired in Cxcr2 deficient zebrafish
larvae where neutrophils are inappropriately retained at the
wound site (18). It has been proposed that altered susceptibility
of neutrophils to gradients at the wound site in Cxcr2 deficient
larvae drives their passive migration away from the wound site.
Our data are compatible with these findings, as the CXCR4
and CXCR2 signaling axis is known to antagonistically regulate
neutrophil retention in other models (42). It would be interesting
to speculate that the combined outcome of signaling through
both CXCR4 and CXCR2 could modulate the reverse migration
of neutrophils during inflammation resolution.
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Taken together our data demonstrate that inhibition of
the CXCL12/CXCR4 signaling axis drives the resolution of
inflammation by increasing neutrophil reverse migration,
and supports the hypothesis that neutrophil desensitization
to gradients at the wound site results in their reverse
migration away from the wound site (16, 18). These data
add to the existing evidence that neutrophil reverse migration
can be targeted pharmacologically to drive the resolution
of inflammation.
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